Role of RET-Regulated GDNF-GFRα1 Endocytosis in Methamphetamine-Induced Neurotoxicity

Mengran Lv, Baoyu Shen, Zhenling Wu, Genmeng Yang, Yuanyuan Cao, Yuan Zhang, Junjie Shu, Wenjuan Dong, Zhenping Hou, Di Jing, Xinjie Zhang, Yuhan Hou, Jing Xu, Lihua Li, Shijun HongInternational Journal of Molecular Sciences 2025 · DOI

TL;DR

Methamphetamine (METH) causes significant neurotoxicity, and while the body tries to protect itself by increasing GDNF, this protective mechanism is disrupted. This study reveals that METH impairs the endocytosis of GDNF with its receptor GFRα1, a process regulated by the RET receptor tyrosine kinase. Crucially, restoring RET levels can mitigate METH-induced damage, suggesting RET-mediated endocytosis is a key target for treating METH neurotoxicity.

What Problem Does This Paper Address?

Methamphetamine (METH) is a potent psychostimulant that wreaks havoc on the brain, leading to neurodegeneration and severe neuropsychiatric conditions. While we know METH causes oxidative stress, mitochondrial dysfunction, and apoptosis, the precise mechanisms by which its neuroprotective pathways are disrupted remain unclear. One such pathway involves Glial cell line-derived neurotrophic factor (GDNF) and its receptor GFRα1, which are known to protect neurons. However, GDNF's protective effect seems to be compromised in the context of METH abuse. This paper aims to unravel why this neuroprotective mechanism fails and identify the key molecular players involved in METH's neurotoxic assault on these pathways.

Methods

The researchers employed a multi-pronged approach to investigate METH's impact on GDNF-GFRα1 signaling:

  • Human Post-Mortem Tissue Analysis: They examined hippocampal tissue from METH abusers and control individuals to assess apoptosis markers (Bax, Bcl-2) and GDNF expression.
  • In Vitro Cell Models: They used HT-22 neuronal cells and co-culture systems (HT-22 with BV2 microglia and MA astrocytes) to study METH's effects on cell morphology, viability, apoptosis, GDNF expression, and release.
  • Receptor Endocytosis Assays: To understand how GDNF and its receptor are internalized, they used:
  • Biotinylation Assay: This technique labels surface proteins and tracks their internalization into the cell.
  • Membrane Protein Fractionation: This method separates proteins located on the cell membrane from those inside the cell.
  • RET Overexpression Studies: They genetically engineered HT-22 cells to overexpress RET to see if this could counteract METH's detrimental effects.
  • Mouse Model: They used a mouse model of acute METH toxicity to validate findings from cell culture studies in a living organism.
  • Western Blotting and Immunohistochemistry: These standard techniques were used to quantify protein levels (GDNF, GFRα1, RET, apoptosis markers) and visualize their distribution in tissues and cells.

Datasets

Not discussed in the paper. The study primarily relies on experimental data generated from human post-mortem samples, cell cultures, and animal models.

Key Insights and Ideas

  • METH's Double-Edged Sword: METH triggers apoptosis and neurotoxicity, but paradoxically, it also increases GDNF expression. This suggests the body attempts a compensatory neuroprotective response.
  • GDNF's Protective Pathway is Blocked: The study reveals that METH disrupts the crucial endocytosis of the GDNF-GFRα1 complex. This means even though GDNF is present, it can't effectively signal to protect the neuron.
  • RET is the Gatekeeper: The transmembrane receptor tyrosine kinase RET plays a critical role in facilitating GDNF-GFRα1 endocytosis. METH exposure leads to a significant decrease in RET expression, effectively shutting down this protective pathway.
  • RET Overexpression is Protective: When researchers boosted RET levels in neuronal cells, it significantly reduced METH-induced cell death, improved cell viability, and restored GDNF-GFRα1 endocytosis. This strongly implicates RET as a key mediator of METH's neurotoxicity.
  • Therapeutic Potential: The findings point towards RET and its role in GDNF-GFRα1 endocytosis as a promising therapeutic target for mitigating METH-induced neurotoxicity and neurodegeneration.

Key Results

  • Human Hippocampus: METH abusers showed increased apoptosis and elevated GDNF expression in their hippocampus compared to controls.
  • In Vitro Neurotoxicity: METH exposure in HT-22 cells led to a dose- and time-dependent decrease in cell morphology and viability, along with increased apoptosis markers (Bax, cleaved caspase-3) and decreased anti-apoptotic markers (Bcl-2).
  • GDNF Upregulation: Concurrently, METH exposure significantly increased GDNF expression and release in both co-cultured cells and mouse hippocampal tissue.
  • Endocytosis Impairment: METH exposure resulted in GFRα1 accumulation on the cell membrane and significantly reduced GDNF-GFRα1 endocytosis in HT-22 cells.
  • RET Downregulation: METH exposure led to a significant decrease in RET expression in HT-22 cells and mouse hippocampal tissue.
  • RET Restoration: Overexpression of RET in HT-22 cells attenuated METH-induced cytotoxicity, apoptosis, and restored GDNF-GFRα1 endocytosis.

Limitations and Future Work

The authors acknowledge a few limitations:

  • Downstream Signaling Pathways: While they identified the disruption of GDNF-GFRα1-RET endocytosis, they did not fully investigate the downstream signaling pathways (like PI3K/AKT and ERK1/2) that are influenced by this complex. Understanding these pathways could provide further insights into METH's neurotoxic mechanisms.
  • Clinically Relevant Exposure Patterns: The study primarily used acute METH exposure models. Future research could explore the effects of more clinically relevant chronic or binge-like exposure patterns to better understand the impact on the human nervous system.

Despite these limitations, the study opens exciting avenues for future research, particularly in developing therapeutic strategies. The authors suggest that targeting RET and its role in GDNF-GFRα1 endocytosis could be a promising approach for treating METH-induced neurotoxicity and withdrawal symptoms. They also highlight the potential of emerging therapies like gene therapy and small-molecule RET agonists.

Summary updated

Abstract

Methamphetamine (METH) is a highly addictive synthetic psychostimulant that can induce severe neurotoxicity, leading to neurodegeneration similar to neurodegenerative diseases. The endocytosis of glial cell line-derived neurotrophic factor (GDNF) and its family receptor alpha 1 (GFRα1), regulated by transmembrane receptor tyrosine kinase (RET), has been shown to resist neurodegeneration. Specifically, the endocytosis of GDNF-GFRα1 mediated by RET is crucial in protecting neurons. Although many molecular mechanisms of METH induced neurotoxicity have been explored, the obstacles to the neuroprotective effect of GDNF in the context of METH induced neurotoxicity are still unclear. In this study, an increase in cell apoptosis and GDNF expression was observed in the hippocampus of METH abusers. METH also induces cell degeneration, cytotoxicity, and GDNF expression and release in hippocampal neuronal (HT-22) cells in a concentration-dependent manner (0.25, 0.5, 1, 2, and 4 mM) and time-dependent manner (3, 6, 12, 24, and 48 h). Meanwhile, after 24 h of exposure to METH (2mM), apoptosis, impaired endocytosis of GDNF-GFRα1, and decreased expression of RET were observed in HT-22 cells and organotypic hippocampal slices of mice. More notably, overexpression of RET weakened METH induced cell degeneration, apoptosis, and disruption of GDNF-GFRα1 endocytosis in HT-22 cells. This study suggests that RET is a key molecule for METH to disrupt GDNF-mediated neuroprotective signaling, and targeting RET-mediated endocytosis of GDNF-GFRα1 may be a potential therapeutic approach for METH induced neurotoxicity and neurodegeneration.
BibTeX
@article{lv2025role,
  author = {Mengran Lv and Baoyu Shen and Zhenling Wu and Genmeng Yang and Yuanyuan Cao and Yuan Zhang and Junjie Shu and Wenjuan Dong and Zhenping Hou and Di Jing and Xinjie Zhang and Yuhan Hou and Jing Xu and Lihua Li and Shijun Hong},
  title = {{Role of RET-Regulated GDNF-GFRα1 Endocytosis in Methamphetamine-Induced Neurotoxicity}},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26199522},
}
Figure